18 related articles for article (PubMed ID: 38669947)
1. A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma.
Yang J; Yang S; Cai J; Chen H; Sun L; Wang J; Hou G; Gu S; Ma J; Ge J
ACS Chem Neurosci; 2024 Jan; 15(2):290-299. PubMed ID: 38141017
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.
Shahbandi A; Chiu FY; Ungerleider NA; Kvadas R; Mheidly Z; Sun MJS; Tian D; Waizman DA; Anderson AY; Machado HL; Pursell ZF; Rao SG; Jackson JG
Nat Cancer; 2022 Dec; 3(12):1513-1533. PubMed ID: 36482233
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of RGS5 regulating gastric cancer mismatch repair protein.
Yang Z; Zhang R; Liu J; Tian S; Zhang H; Zeng L; Zhang Y; Gao L; Wang M; Shan W; Liu J
Mol Carcinog; 2024 Jun; ():. PubMed ID: 38860604
[TBL] [Abstract][Full Text] [Related]
4. Erratum: New insights into the role of macrophages in cancer immunotherapy.
Frontiers Production Office
Front Immunol; 2024; 15():1427337. PubMed ID: 38817610
[TBL] [Abstract][Full Text] [Related]
5. IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Fan Y; Wang X; Li Y
Int J Med Sci; 2021; 18(14):3342-3352. PubMed ID: 34400904
[No Abstract] [Full Text] [Related]
6. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the role of interferon gamma-inducible protein 30 on immune infiltration and prognosis in clear cell renal cell carcinoma.
Wen X; Lei L; Wang F; Wang Y
Biomol Biomed; 2024 Mar; 24(2):411-422. PubMed ID: 37991414
[TBL] [Abstract][Full Text] [Related]
8. TIMELESS upregulates PD-L1 expression and exerts an immunosuppressive role in breast cancer.
Dong X; Dai H; Lin Y; Sheng X; Li Y; Wang Y; Zhang X; Jiang S; Yin W; Lu J
J Transl Med; 2023 Jun; 21(1):400. PubMed ID: 37340461
[TBL] [Abstract][Full Text] [Related]
9. Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8
Shuai C; Yang X; Pan H; Han W
Front Oncol; 2020; 10():582863. PubMed ID: 33102239
[No Abstract] [Full Text] [Related]
10. IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer.
Li L; Fei Y; Dong T; Song Y; Chen X; Zhang H; Zhou H; Liang M; Tang J
Int Immunopharmacol; 2024 May; 133():112093. PubMed ID: 38669947
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
